Pharma News
-
CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells
Pharma | News | 0 Comment | 20 Jun, 2019
CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, on 19 June 2019, announced that one of its leading drug candida...Read more
-
Ferring Pharma collaborates with WOOM
Pharma | News | 0 Comment | 19 Jun, 2019
Ferring Pharmaceuticals and WOOM have announced a collaboration, which aims to improve and shorten the fertility journeys of the one in six couples who have difficulty conceiving.1 The WOO...Read more
-
Japan the first to approve Roche’s personalised medicine Rozlytrek
Pharma | News | 0 Comment | 19 Jun, 2019
Roche has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek® (entrectinib) for the treatment of adult and paediatric patients with neurot...Read more
-
Daiichi Sankyo’s VANFLYTA® receives approval for the treatment of Relapsed/Refractory FLT3-ITD AML
Pharma | News | 0 Comment | 18 Jun, 2019
Daiichi Sankyo Company has announced that the Ministry of Health, Labor and Welfare (MHLW) of Japan has approved VANFLYTA® (quizartinib), an oral FLT3 inhibitor, for the treatment of ad...Read more
-
Pfizer announces results from Xeljanz® Xr oral shift study
Pharma | News | 0 Comment | 18 Jun, 2019
Pfizer Inc. has announced positive results from ORAL Shift, a Phase 3b/4 study in adult patients with moderately to severely active rheumatoid arthritis (RA). Patients who achieved low dise...Read more
-
Pfizer to acquire Array BioPharma in a $11.4B deal
Pharma | News | 0 Comment | 18 Jun, 2019
Pfizer Inc. and Array BioPharma Inc. have announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array, a commercial stage biopharmaceutical com...Read more
-
85% shares voted to date to support merger of Flex Pharma with Salarius Pharma
Pharma | News | 0 Comment | 17 Jun, 2019
Flex Pharma has announced that approximately 85% of shares voted to date support the proposed merger with Salarius Pharmaceuticals, LLC, an epigenetic oncology company. However, in ord...Read more
-
Terns Pharmaceuticals initiates Ph1 clinical trial of TERN 101
Pharma | News | 0 Comment | 17 Jun, 2019
Terns Pharmaceuticals has announced the initiation of Phase 1 clinical trial of TERN-101, a farnesoid X receptor (FXR) agonist, being developed for the treatment of non-alcoholic steat...Read more
-
Amgen and Allergan's KANJINTI gets FDA approval
Pharma | News | 0 Comment | 14 Jun, 2019
Amgen and Allergan plc have announced that the U.S. Food and Drug Administration (FDA) has approved KANJINTI™ (trastuzumab-anns) for all approved indications of the reference pro...Read more
-
Novartis continues to innovate in CML
Pharma | News | 0 Comment | 14 Jun, 2019
Long-term follow-up data from the ongoing, pivotal open-label ENESTfreedom and ENESTop trials showed sustained treatment-free remission (TFR) after stopping frontline and second-line Tasign...Read more
-
Pharma | News | 0 Comment | 14 Jun, 2019
Dr. Reddy’s Laboratories Limited has announced that it has entered into a definitive asset purchase agreement with Upsher-Smith Laboratories pursuant to which Dr. Redd...Read more
-
Sun Pharma’s ILUMYA improves joint and skin symptoms of Psoriatic Arthritis
Pharma | News | 0 Comment | 14 Jun, 2019
Sun Pharmaceutical Industries Ltd. recently announced interim results from a Phase 2 study of interleukin-23 (IL-23) inhibitor ILUMYA™ (tildrakizumab-asmn) in patients with activ...Read more
-
Amcor completes acquisition of Bemis
Pharma | News | 0 Comment | 12 Jun, 2019
Amcor is a global leader in developing and producing responsible packaging for food, beverage, pharmaceutical, medical, home- and personal-care, and other products. Amcor has announced the...Read more
-
Dulaglutide reduces cardiovascular disease in Type-2 diabetic people
Pharma | News | 0 Comment | 10 Jun, 2019
The Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) trial has found dulaglutide, an injectable, glucagon-like peptide-1 (GLP-1) receptor agonist, dem...Read more
-
Calliditas Therapeutics to commercialize autoimmune drug in China, Singapore
Pharma | News | 0 Comment | 11 Jun, 2019
Sweden based Calliditas Therapeutics AB (“Calliditas”) and US based Everest Medicines II Limited (“Everest Medicines”) announced that they have entered into a licens...Read more
-
PTC gets FDA nod for the expansion of the EMFLAZA® labeling
Pharma | News | 0 Comment | 10 Jun, 2019
PTC Therapeutics is a science-led, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits ...Read more
-
First patient dosed in the FRAMES phase 2 trial in Friedreich’s Ataxia
Pharma | News | 0 Comment | 07 Jun, 2019
Minoryx Therapeutics, a company specializing in the development of new drugs for orphan diseases, announced on 4 June 2019, that the first patient has been dosed with its lead candidate, le...Read more
-
FSD Pharma adds two more prominent Cannabis researchers to Scientific Advisory Board
Pharma | News | 0 Comment | 07 Jun, 2019
FSD Pharma Inc. has announced the addition of two distinguished cannabis researchers to the company’s Scientific Advisory Board. “It is with great pride tha...Read more
